Casa Grande Dialysis (FMC) is a medicare approved dialysis facility center in Casa Grande, Arizona and it has 16 dialysis stations. It is located in Pinal county at 1875 E Sabin Dr, Casa Grande, AZ, 85122. You can reach out to the office of Casa Grande Dialysis (FMC) at (520) 836-2566. This dialysis clinic is managed and/or owned by Renal Care Group Inc.. Casa Grande Dialysis (FMC) has the following ownership type - Profit. It was first certified by medicare in September, 1995. The medicare id for this facility is 032561 and it accepts patients under medicare ESRD program.
| Name | Casa Grande Dialysis (FMC) |
|---|---|
| Location | 1875 E Sabin Dr, Casa Grande, Arizona |
| No. of Dialysis Stations | 16 |
| Medicare ID | 032561 |
| Managed By | Renal Care Group Inc. |
| Ownership Type | Profit |
| Late Shifts | Yes |
| 1875 E Sabin Dr, Casa Grande, Arizona, 85122 | |
| (520) 836-2566 | |
News Archive
Northwest Biotherapeutics today announced that the company has received approximately $490,000 in two grants under the Qualified Therapeutic Discovery Project Grants Program. The maximum award was received for both grants.
The Philadelphia Inquirer reports that Congress "is considering" a $3 million pilot program, that "would establish a Women Veterans and Service Members Joint Health Resource Center in South Jersey. The effort, which could be replicated across the country, would provide 'navigators' to connect women in the military and female veterans to health care, including gynecological, obstetric, and breast exams, available through the Department of Veterans Affairs and civilian facilities."
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, announces that a treatment utilising a DNA vaccine based on its ImmunoBody® technology, in combination with ImmuneRegen BioSciences, Inc.®'s lead compound, Homspera®, has significantly improved the immune response of the vaccine in an animal model. Follow-up studies are currently being performed to optimize the effects of Homspera in enhancing the next generation of Scancell's cancer vaccines.
A new study reveals an association between prenatal exposure to environmental pollutants and elevated body mass index (BMI) during the first three years of life, as reported in the January 2009 issue of the peer-reviewed journal Environmental Health Perspectives (EHP).
› Verified 9 days ago
| NPI Number | 1487766291 |
| Organization Name | Fresenius Medical Care Casa Grande |
| Doing Business As | Renal Care Group Arizona, Llc |
| Address | 1875 E Sabin Dr. Casa Grande, Arizona, 85122 |
| Phone Number | (520) 836-2566 |
News Archive
Northwest Biotherapeutics today announced that the company has received approximately $490,000 in two grants under the Qualified Therapeutic Discovery Project Grants Program. The maximum award was received for both grants.
The Philadelphia Inquirer reports that Congress "is considering" a $3 million pilot program, that "would establish a Women Veterans and Service Members Joint Health Resource Center in South Jersey. The effort, which could be replicated across the country, would provide 'navigators' to connect women in the military and female veterans to health care, including gynecological, obstetric, and breast exams, available through the Department of Veterans Affairs and civilian facilities."
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, announces that a treatment utilising a DNA vaccine based on its ImmunoBody® technology, in combination with ImmuneRegen BioSciences, Inc.®'s lead compound, Homspera®, has significantly improved the immune response of the vaccine in an animal model. Follow-up studies are currently being performed to optimize the effects of Homspera in enhancing the next generation of Scancell's cancer vaccines.
A new study reveals an association between prenatal exposure to environmental pollutants and elevated body mass index (BMI) during the first three years of life, as reported in the January 2009 issue of the peer-reviewed journal Environmental Health Perspectives (EHP).
› Verified 9 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 65% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 18% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 17% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 56% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 29% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 15% | 14% |
News Archive
Northwest Biotherapeutics today announced that the company has received approximately $490,000 in two grants under the Qualified Therapeutic Discovery Project Grants Program. The maximum award was received for both grants.
The Philadelphia Inquirer reports that Congress "is considering" a $3 million pilot program, that "would establish a Women Veterans and Service Members Joint Health Resource Center in South Jersey. The effort, which could be replicated across the country, would provide 'navigators' to connect women in the military and female veterans to health care, including gynecological, obstetric, and breast exams, available through the Department of Veterans Affairs and civilian facilities."
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, announces that a treatment utilising a DNA vaccine based on its ImmunoBody® technology, in combination with ImmuneRegen BioSciences, Inc.®'s lead compound, Homspera®, has significantly improved the immune response of the vaccine in an animal model. Follow-up studies are currently being performed to optimize the effects of Homspera in enhancing the next generation of Scancell's cancer vaccines.
A new study reveals an association between prenatal exposure to environmental pollutants and elevated body mass index (BMI) during the first three years of life, as reported in the January 2009 issue of the peer-reviewed journal Environmental Health Perspectives (EHP).
› Verified 9 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 59% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 20% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 21% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 61% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 23% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 16% | 12% |
News Archive
Northwest Biotherapeutics today announced that the company has received approximately $490,000 in two grants under the Qualified Therapeutic Discovery Project Grants Program. The maximum award was received for both grants.
The Philadelphia Inquirer reports that Congress "is considering" a $3 million pilot program, that "would establish a Women Veterans and Service Members Joint Health Resource Center in South Jersey. The effort, which could be replicated across the country, would provide 'navigators' to connect women in the military and female veterans to health care, including gynecological, obstetric, and breast exams, available through the Department of Veterans Affairs and civilian facilities."
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, announces that a treatment utilising a DNA vaccine based on its ImmunoBody® technology, in combination with ImmuneRegen BioSciences, Inc.®'s lead compound, Homspera®, has significantly improved the immune response of the vaccine in an animal model. Follow-up studies are currently being performed to optimize the effects of Homspera in enhancing the next generation of Scancell's cancer vaccines.
A new study reveals an association between prenatal exposure to environmental pollutants and elevated body mass index (BMI) during the first three years of life, as reported in the January 2009 issue of the peer-reviewed journal Environmental Health Perspectives (EHP).
› Verified 9 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 85% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 15% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 71% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 17% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 12% | 12% |
News Archive
Northwest Biotherapeutics today announced that the company has received approximately $490,000 in two grants under the Qualified Therapeutic Discovery Project Grants Program. The maximum award was received for both grants.
The Philadelphia Inquirer reports that Congress "is considering" a $3 million pilot program, that "would establish a Women Veterans and Service Members Joint Health Resource Center in South Jersey. The effort, which could be replicated across the country, would provide 'navigators' to connect women in the military and female veterans to health care, including gynecological, obstetric, and breast exams, available through the Department of Veterans Affairs and civilian facilities."
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, announces that a treatment utilising a DNA vaccine based on its ImmunoBody® technology, in combination with ImmuneRegen BioSciences, Inc.®'s lead compound, Homspera®, has significantly improved the immune response of the vaccine in an animal model. Follow-up studies are currently being performed to optimize the effects of Homspera in enhancing the next generation of Scancell's cancer vaccines.
A new study reveals an association between prenatal exposure to environmental pollutants and elevated body mass index (BMI) during the first three years of life, as reported in the January 2009 issue of the peer-reviewed journal Environmental Health Perspectives (EHP).
› Verified 9 days ago
| Dialysis patients with Hemoglobin data | 74 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 12 |
News Archive
Northwest Biotherapeutics today announced that the company has received approximately $490,000 in two grants under the Qualified Therapeutic Discovery Project Grants Program. The maximum award was received for both grants.
The Philadelphia Inquirer reports that Congress "is considering" a $3 million pilot program, that "would establish a Women Veterans and Service Members Joint Health Resource Center in South Jersey. The effort, which could be replicated across the country, would provide 'navigators' to connect women in the military and female veterans to health care, including gynecological, obstetric, and breast exams, available through the Department of Veterans Affairs and civilian facilities."
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, announces that a treatment utilising a DNA vaccine based on its ImmunoBody® technology, in combination with ImmuneRegen BioSciences, Inc.®'s lead compound, Homspera®, has significantly improved the immune response of the vaccine in an animal model. Follow-up studies are currently being performed to optimize the effects of Homspera in enhancing the next generation of Scancell's cancer vaccines.
A new study reveals an association between prenatal exposure to environmental pollutants and elevated body mass index (BMI) during the first three years of life, as reported in the January 2009 issue of the peer-reviewed journal Environmental Health Perspectives (EHP).
› Verified 9 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 159 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 1320 |
| Percentage of adult patients getting regular hemodialysis at the center | 99 |
News Archive
Northwest Biotherapeutics today announced that the company has received approximately $490,000 in two grants under the Qualified Therapeutic Discovery Project Grants Program. The maximum award was received for both grants.
The Philadelphia Inquirer reports that Congress "is considering" a $3 million pilot program, that "would establish a Women Veterans and Service Members Joint Health Resource Center in South Jersey. The effort, which could be replicated across the country, would provide 'navigators' to connect women in the military and female veterans to health care, including gynecological, obstetric, and breast exams, available through the Department of Veterans Affairs and civilian facilities."
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, announces that a treatment utilising a DNA vaccine based on its ImmunoBody® technology, in combination with ImmuneRegen BioSciences, Inc.®'s lead compound, Homspera®, has significantly improved the immune response of the vaccine in an animal model. Follow-up studies are currently being performed to optimize the effects of Homspera in enhancing the next generation of Scancell's cancer vaccines.
A new study reveals an association between prenatal exposure to environmental pollutants and elevated body mass index (BMI) during the first three years of life, as reported in the January 2009 issue of the peer-reviewed journal Environmental Health Perspectives (EHP).
› Verified 9 days ago
| Adult patients getting regular peritoneal dialysis at the center | 33 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 214 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 98 |
News Archive
Northwest Biotherapeutics today announced that the company has received approximately $490,000 in two grants under the Qualified Therapeutic Discovery Project Grants Program. The maximum award was received for both grants.
The Philadelphia Inquirer reports that Congress "is considering" a $3 million pilot program, that "would establish a Women Veterans and Service Members Joint Health Resource Center in South Jersey. The effort, which could be replicated across the country, would provide 'navigators' to connect women in the military and female veterans to health care, including gynecological, obstetric, and breast exams, available through the Department of Veterans Affairs and civilian facilities."
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, announces that a treatment utilising a DNA vaccine based on its ImmunoBody® technology, in combination with ImmuneRegen BioSciences, Inc.®'s lead compound, Homspera®, has significantly improved the immune response of the vaccine in an animal model. Follow-up studies are currently being performed to optimize the effects of Homspera in enhancing the next generation of Scancell's cancer vaccines.
A new study reveals an association between prenatal exposure to environmental pollutants and elevated body mass index (BMI) during the first three years of life, as reported in the January 2009 issue of the peer-reviewed journal Environmental Health Perspectives (EHP).
› Verified 9 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Casa Grande Dialysis (FMC) with elevated calcium levels.
| Patients with hypercalcemia | 204 |
| Hypercalcemia patient months | 1757 |
| Patients with Serumphosphor | 212 |
| Patients with Serumphosphor less than 3.5 mg/dL | 10 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 25 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 29 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 24 |
| Patients with Serumphosphor greater than 7 mg/dL | 12 |
News Archive
Northwest Biotherapeutics today announced that the company has received approximately $490,000 in two grants under the Qualified Therapeutic Discovery Project Grants Program. The maximum award was received for both grants.
The Philadelphia Inquirer reports that Congress "is considering" a $3 million pilot program, that "would establish a Women Veterans and Service Members Joint Health Resource Center in South Jersey. The effort, which could be replicated across the country, would provide 'navigators' to connect women in the military and female veterans to health care, including gynecological, obstetric, and breast exams, available through the Department of Veterans Affairs and civilian facilities."
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, announces that a treatment utilising a DNA vaccine based on its ImmunoBody® technology, in combination with ImmuneRegen BioSciences, Inc.®'s lead compound, Homspera®, has significantly improved the immune response of the vaccine in an animal model. Follow-up studies are currently being performed to optimize the effects of Homspera in enhancing the next generation of Scancell's cancer vaccines.
A new study reveals an association between prenatal exposure to environmental pollutants and elevated body mass index (BMI) during the first three years of life, as reported in the January 2009 issue of the peer-reviewed journal Environmental Health Perspectives (EHP).
› Verified 9 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 120 |
| Patient months included in arterial venous fistula and catheter summaries | 920 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 81 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 10 |
News Archive
Northwest Biotherapeutics today announced that the company has received approximately $490,000 in two grants under the Qualified Therapeutic Discovery Project Grants Program. The maximum award was received for both grants.
The Philadelphia Inquirer reports that Congress "is considering" a $3 million pilot program, that "would establish a Women Veterans and Service Members Joint Health Resource Center in South Jersey. The effort, which could be replicated across the country, would provide 'navigators' to connect women in the military and female veterans to health care, including gynecological, obstetric, and breast exams, available through the Department of Veterans Affairs and civilian facilities."
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, announces that a treatment utilising a DNA vaccine based on its ImmunoBody® technology, in combination with ImmuneRegen BioSciences, Inc.®'s lead compound, Homspera®, has significantly improved the immune response of the vaccine in an animal model. Follow-up studies are currently being performed to optimize the effects of Homspera in enhancing the next generation of Scancell's cancer vaccines.
A new study reveals an association between prenatal exposure to environmental pollutants and elevated body mass index (BMI) during the first three years of life, as reported in the January 2009 issue of the peer-reviewed journal Environmental Health Perspectives (EHP).
› Verified 9 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 144 |
| Hospitalization Rate in facility | 201.9 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 309.1 |
| Hospitalization Rate: Lower Confidence Limit | 140.7 |
News Archive
Northwest Biotherapeutics today announced that the company has received approximately $490,000 in two grants under the Qualified Therapeutic Discovery Project Grants Program. The maximum award was received for both grants.
The Philadelphia Inquirer reports that Congress "is considering" a $3 million pilot program, that "would establish a Women Veterans and Service Members Joint Health Resource Center in South Jersey. The effort, which could be replicated across the country, would provide 'navigators' to connect women in the military and female veterans to health care, including gynecological, obstetric, and breast exams, available through the Department of Veterans Affairs and civilian facilities."
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, announces that a treatment utilising a DNA vaccine based on its ImmunoBody® technology, in combination with ImmuneRegen BioSciences, Inc.®'s lead compound, Homspera®, has significantly improved the immune response of the vaccine in an animal model. Follow-up studies are currently being performed to optimize the effects of Homspera in enhancing the next generation of Scancell's cancer vaccines.
A new study reveals an association between prenatal exposure to environmental pollutants and elevated body mass index (BMI) during the first three years of life, as reported in the January 2009 issue of the peer-reviewed journal Environmental Health Perspectives (EHP).
› Verified 9 days ago
The rate of readmission show you whether patients who were being treated regularly at Casa Grande Dialysis (FMC) were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 30.4 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 41.5 |
| Readmission Rate: Lower Confidence Limit | 21.1 |
News Archive
Northwest Biotherapeutics today announced that the company has received approximately $490,000 in two grants under the Qualified Therapeutic Discovery Project Grants Program. The maximum award was received for both grants.
The Philadelphia Inquirer reports that Congress "is considering" a $3 million pilot program, that "would establish a Women Veterans and Service Members Joint Health Resource Center in South Jersey. The effort, which could be replicated across the country, would provide 'navigators' to connect women in the military and female veterans to health care, including gynecological, obstetric, and breast exams, available through the Department of Veterans Affairs and civilian facilities."
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, announces that a treatment utilising a DNA vaccine based on its ImmunoBody® technology, in combination with ImmuneRegen BioSciences, Inc.®'s lead compound, Homspera®, has significantly improved the immune response of the vaccine in an animal model. Follow-up studies are currently being performed to optimize the effects of Homspera in enhancing the next generation of Scancell's cancer vaccines.
A new study reveals an association between prenatal exposure to environmental pollutants and elevated body mass index (BMI) during the first three years of life, as reported in the January 2009 issue of the peer-reviewed journal Environmental Health Perspectives (EHP).
› Verified 9 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Casa Grande Dialysis (FMC) get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .69 (As Expected) |
| SIR: Upper Confidence Limit | 1.44 |
| SIR: Lower Confidence Limit | .28 |
News Archive
Northwest Biotherapeutics today announced that the company has received approximately $490,000 in two grants under the Qualified Therapeutic Discovery Project Grants Program. The maximum award was received for both grants.
The Philadelphia Inquirer reports that Congress "is considering" a $3 million pilot program, that "would establish a Women Veterans and Service Members Joint Health Resource Center in South Jersey. The effort, which could be replicated across the country, would provide 'navigators' to connect women in the military and female veterans to health care, including gynecological, obstetric, and breast exams, available through the Department of Veterans Affairs and civilian facilities."
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, announces that a treatment utilising a DNA vaccine based on its ImmunoBody® technology, in combination with ImmuneRegen BioSciences, Inc.®'s lead compound, Homspera®, has significantly improved the immune response of the vaccine in an animal model. Follow-up studies are currently being performed to optimize the effects of Homspera in enhancing the next generation of Scancell's cancer vaccines.
A new study reveals an association between prenatal exposure to environmental pollutants and elevated body mass index (BMI) during the first three years of life, as reported in the January 2009 issue of the peer-reviewed journal Environmental Health Perspectives (EHP).
› Verified 9 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Casa Grande Dialysis (FMC)'s rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 123 |
| Transfusion Rate in facility | 37.2 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 75.4 |
| Transfusion Rate: Lower Confidence Limit | 20 |
News Archive
Northwest Biotherapeutics today announced that the company has received approximately $490,000 in two grants under the Qualified Therapeutic Discovery Project Grants Program. The maximum award was received for both grants.
The Philadelphia Inquirer reports that Congress "is considering" a $3 million pilot program, that "would establish a Women Veterans and Service Members Joint Health Resource Center in South Jersey. The effort, which could be replicated across the country, would provide 'navigators' to connect women in the military and female veterans to health care, including gynecological, obstetric, and breast exams, available through the Department of Veterans Affairs and civilian facilities."
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, announces that a treatment utilising a DNA vaccine based on its ImmunoBody® technology, in combination with ImmuneRegen BioSciences, Inc.®'s lead compound, Homspera®, has significantly improved the immune response of the vaccine in an animal model. Follow-up studies are currently being performed to optimize the effects of Homspera in enhancing the next generation of Scancell's cancer vaccines.
A new study reveals an association between prenatal exposure to environmental pollutants and elevated body mass index (BMI) during the first three years of life, as reported in the January 2009 issue of the peer-reviewed journal Environmental Health Perspectives (EHP).
› Verified 9 days ago
The rate of mortality show you whether patients who were being treated regularly at Casa Grande Dialysis (FMC) lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 661 |
| Mortality Rate in facility | 17.3 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 21.6 |
| Mortality Rate: Lower Confidence Limit | 13.6 |
News Archive
Northwest Biotherapeutics today announced that the company has received approximately $490,000 in two grants under the Qualified Therapeutic Discovery Project Grants Program. The maximum award was received for both grants.
The Philadelphia Inquirer reports that Congress "is considering" a $3 million pilot program, that "would establish a Women Veterans and Service Members Joint Health Resource Center in South Jersey. The effort, which could be replicated across the country, would provide 'navigators' to connect women in the military and female veterans to health care, including gynecological, obstetric, and breast exams, available through the Department of Veterans Affairs and civilian facilities."
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, announces that a treatment utilising a DNA vaccine based on its ImmunoBody® technology, in combination with ImmuneRegen BioSciences, Inc.®'s lead compound, Homspera®, has significantly improved the immune response of the vaccine in an animal model. Follow-up studies are currently being performed to optimize the effects of Homspera in enhancing the next generation of Scancell's cancer vaccines.
A new study reveals an association between prenatal exposure to environmental pollutants and elevated body mass index (BMI) during the first three years of life, as reported in the January 2009 issue of the peer-reviewed journal Environmental Health Perspectives (EHP).
› Verified 9 days ago
Western Skies Dialysis Inc. Location: 1041 N Arizola Rd, Casa Grande, Arizona, 85122 Phone: (520) 836-5883 |
Casa Grande Dialysis (FMC) Location: 1875 E Sabin Dr, Casa Grande, Arizona, 85122 Phone: (520) 836-2566 |
News Archive
Northwest Biotherapeutics today announced that the company has received approximately $490,000 in two grants under the Qualified Therapeutic Discovery Project Grants Program. The maximum award was received for both grants.
The Philadelphia Inquirer reports that Congress "is considering" a $3 million pilot program, that "would establish a Women Veterans and Service Members Joint Health Resource Center in South Jersey. The effort, which could be replicated across the country, would provide 'navigators' to connect women in the military and female veterans to health care, including gynecological, obstetric, and breast exams, available through the Department of Veterans Affairs and civilian facilities."
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, announces that a treatment utilising a DNA vaccine based on its ImmunoBody® technology, in combination with ImmuneRegen BioSciences, Inc.®'s lead compound, Homspera®, has significantly improved the immune response of the vaccine in an animal model. Follow-up studies are currently being performed to optimize the effects of Homspera in enhancing the next generation of Scancell's cancer vaccines.
A new study reveals an association between prenatal exposure to environmental pollutants and elevated body mass index (BMI) during the first three years of life, as reported in the January 2009 issue of the peer-reviewed journal Environmental Health Perspectives (EHP).
› Verified 9 days ago